Transplant
Conference Coverage
Myeloma: Isa-KRd Induction Shows High MRD Responses
Interim analysis of first MIDAS trial findings shows “highest rate of response and MRD negativity to date.”
Conference Coverage
Daratumumab Quadruplet Supported Transplant-Ineligible MM
A phase-3 study showed that adding daratumumab to VRd yields a primary endpoint of MRD negativity in patients newly diagnosed with myeloma.
Conference Coverage
Myeloma: Daratumumab Plus Lenalidomide Improves MRD Outcomes
New research shows that adding daratumumab to maintenance therapy improves MRD and PFS outcomes in multiple myeloma.
Conference Coverage
No Matched Sibling Donor? Sickle Cell Experts Debate Next-Best Option
SCD specialists differ on the best treatment choices for patients who lack an available matched sibling donor.
Perspectives
In Colorectal Cancer, Donating Half a Liver Could Save Lives
Doctor has been developing a passion for being able to transplant cancer patients and use organ transplant techniques to be able to do complex...
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
From the Journals
Liver Transplant Delays Progression in Colorectal Metastasis
Researchers evaluated 33 patients with colorectal cancer and unresectable liver metastasis who were eligible for liver transplants.
News
FDA Approves Axatilimab for Chronic GVHD
For children and adults with graft versus host disease, a first-in-class monoclonal antibody axatilimab has received FDA approval.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Conference Coverage
CAR T for B-ALL: Game Changer For Young Patients?
Survival rises as tisagenlecleucel therapy reaches those with less severe disease, displacing HSCT.
Latest News
Gene Tests Could Predict if a Drug Will Work for a Patient
Pharmacogenetics could help physicians determine which patients would and would not benefit from medications.